June 05, 2013
Merck & Cie and Bayer Pharma AG on Tuesday accused generic-drug maker Watson Laboratories Inc. of infringing the patent for their contraceptive Safyral by seeking approval for a generic version of the drug, according to identical suits filed in federal courts in Delaware and Nevada.